These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10378889)

  • 21. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias.
    Hayette S; Thomas X; Bertrand Y; Tigaud I; Callanan M; Thiebaut A; Charrin C; Archimbaud E; Magaud JP; Rimokh R
    Leukemia; 1997 Oct; 11(10):1696-9. PubMed ID: 9324291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features.
    Fizzotti M; Cimino G; Pisegna S; Alimena G; Quartarone C; Mandelli F; Pelicci PG; Lo Coco F
    Blood; 1995 May; 85(10):2685-90. PubMed ID: 7742527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormalities of tumor suppressor genes P16 and P15 in primary maxillofacial squamous cell carcinomas.
    Zhao Y; Zhang S; Fu B; Xiao C
    Cancer Genet Cytogenet; 1999 Jul; 112(1):26-33. PubMed ID: 10432931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T cell leukemia.
    Nishimura S; Asou N; Suzushima H; Okubo T; Fujimoto T; Osato M; Yamasaki H; Lisha L; Takatsuki K
    Leukemia; 1995 Apr; 9(4):598-604. PubMed ID: 7723391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma.
    Child FJ; Scarisbrick JJ; Calonje E; Orchard G; Russell-Jones R; Whittaker SJ
    J Invest Dermatol; 2002 Jun; 118(6):941-8. PubMed ID: 12060387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of evidence for mutations or deletions in the CDKN2A/p16 and CDKN2B/p15 genes of Brazilian neuroblastoma patients.
    Bassi CL; Martelli L; Cipolotti R; Scrideli CA; Defávery R; Tone LG
    Braz J Med Biol Res; 2004 Nov; 37(11):1683-7. PubMed ID: 15517085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.
    Bisogna M; Calvano JE; Ho GH; Orlow I; Cordón-Cardó C; Borgen PI; Van Zee KJ
    Cancer Genet Cytogenet; 2001 Mar; 125(2):131-8. PubMed ID: 11369056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variable expression of p16 protein in patients with acute myeloid leukemia without gross rearrangements at the DNA level.
    Jamal R; Thomas NS; Gale RE; Linch DC
    Leukemia; 1996 Apr; 10(4):629-36. PubMed ID: 8618439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletion or lack of expression of CDKN2 (CDK4I/MTS1/INK4A) and MTS2 (INK4B) in acute lymphoblastic leukemia cell lines reflects the phenotype of the uncultured primary leukemia cells.
    Jagasia AA; Sher DA; Le Moine PJ; Kim DH; Moldwin RL; Smith SD; Diaz MO
    Leukemia; 1996 Apr; 10(4):624-8. PubMed ID: 8618438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients.
    Mochizuki S; Iwadate Y; Namba H; Yoshida Y; Yamaura A; Sakiyama S; Tagawa M
    Int J Oncol; 1999 Nov; 15(5):983-9. PubMed ID: 10536183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The methylthioadenosine phosphorylase gene is frequently co-deleted with the p16INK4a gene in acute type adult T-cell leukemia.
    Hori Y; Hori H; Yamada Y; Carrera CJ; Tomonaga M; Kamihira S; Carson DA; Nobori T
    Int J Cancer; 1998 Jan; 75(1):51-6. PubMed ID: 9426690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T; Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult T-cell leukemia: structures and expression of the p53 gene.
    Sugito S; Yamato K; Sameshima Y; Yokota J; Yano S; Miyoshi I
    Int J Cancer; 1991 Dec; 49(6):880-5. PubMed ID: 1959992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of methylthioadenosine phosphorylase (MTAP) and p16 gene deletion in T cell acute lymphoblastic leukemia by real-time quantitative PCR assay.
    M'soka TJ; Nishioka J; Taga A; Kato K; Kawasaki H; Yamada Y; Yu A; Komada Y; Nobori T
    Leukemia; 2000 May; 14(5):935-40. PubMed ID: 10803528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage.
    Nakagawa K; Conrad NK; Williams JP; Johnson BE; Kelley MJ
    Oncogene; 1995 Nov; 11(9):1843-51. PubMed ID: 7478613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent deletion and 5' CpG island methylation of the p16 gene in primary malignant lymphoma of the brain.
    Zhang SJ; Endo S; Ichikawa T; Washiyama K; Kumanishi T
    Cancer Res; 1998 Mar; 58(6):1231-7. PubMed ID: 9515810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autocrine and/or paracrine growth of adult T-cell leukaemia tumour cells by interleukin 15.
    Kukita T; Arima N; Matsushita K; Arimura K; Ohtsubo H; Sakaki Y; Fujiwara H; Ozaki A; Matsumoto T; Tei C
    Br J Haematol; 2002 Nov; 119(2):467-74. PubMed ID: 12406087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
    Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T
    Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia.
    Tsirigotis P; Pappa V; Labropoulos S; Papageorgiou S; Kontsioti F; Dervenoulas J; Papageorgiou E; Panani A; Mantzios G; Economopoulos T; Raptis S
    Eur J Haematol; 2006 Mar; 76(3):230-6. PubMed ID: 16412137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia.
    Zhou M; Gu L; Yeager AM; Findley HW
    Pediatr Hematol Oncol; 1997; 14(2):141-50. PubMed ID: 9089742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.